Although a favorable trend in hepatitis B mortality was observed between 1990 and 2019, a recent analysis indicated that this pace of decline remains insufficient, as persistent gaps in diagnosis and treatment continue to fuel the burden of advanced liver disease. 3 , 4 Consequently, China faces formidable challenges in achi
← all excerpts
Long-term Dynamic Virological Response Patterns and Clinical Outcomes in Hepatitis B Virus-related Cirrhosis: A Real-world 10-year Cohort Study.
1
—
—